March 25, 2025: Food & Drug Administration Says Trulicity Shortage Still Active as Lawsuits Increase On February 21, 2025, the Food & Drug Administration lifted many of the semaglutide injection shortages
Yet debate continues over who should use them and when
For those suffering from joint pain or arthritis, BPC 157 may offer relief
Applies to starter doses : The promotion covers the 0.25 mg and 0.5 mg doses of either medication
Discover current costs, generic pricing, and how much patients now pay for treatment
The GLP-1 obesity market overall is projected to grow dramatically in 2026 and beyond, driven by reduced prices, expanded Medicare and Medicaid coverage, and the newfound accessibility of oral options